Practice guidelines for interstitial lung diseases: Widening the reach

por Montesi, Sydney B.
Publicado 2020

Molecular Imaging of Pulmonary Fibrosis: Another Step Forward

por Montesi, Sydney B.
Publicado 2021

2020 American Thoracic Society BEAR Cage Winning Proposal: Collagen-targeted Positron Emission Tomography Imaging as a Novel Biomarker of Treatment Response in Idiopathic Pulmonary...

por Montesi, Sydney B.
Publicado 2021

Fibroblast Activating Protein: Skimming the Surface of Molecular Imaging to Assess Fibrotic Disease Activity

por Montesi, Sydney B., Horowitz, Jeffrey C.
Publicado 2022

FKBP13: A New Player on the Block in Endoplasmic Reticulum Stress and Lung Fibrosis

por Li, Xiaoyun, Montesi, Sydney B., Zhang, Yingze
Publicado 2021

Editorial: Fibrotic Lung Disease—“Lumping” the Progressive Phenotype

por Kulkarni, Tejaswini, Montesi, Sydney B., Collins, Bridget F.
Publicado 2022

Treating lung cancer in patients with interstitial lung disease: what do we know?

por Graur, Alexander, Montesi, Sydney B., Lanuti, Michael, Fintelmann, Florian J.
Publicado 2023

Dynamic Contrast-enhanced MRI Demonstrates Pulmonary Microvascular Abnormalities Months After SARS-CoV-2 Infection

por Zhou, Iris Y., Mascia, Molly, Alba, George A., Magaletta, Michael, Ginns, Leo C., Caravan, Peter, Montesi, Sydney B.
Publicado 2023

Clinical role, safety and diagnostic accuracy of percutaneous transthoracic needle biopsy in the evaluation of pulmonary consolidation

por Kiranantawat, Nantaka, McDermott, Shaunagh, Fintelmann, Florian J., Montesi, Sydney B., Price, Melissa C., Digumarthy, Subba R., Sharma, Amita
Publicado 2019

Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody

por Sclafani, A., D’Silva, K. M., Little, B. P., Miloslavsky, E. M., Locascio, J. J., Sharma, A., Montesi, S. B.
Publicado 2019

Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis

por Montesi, Sydney B, Mathai, Susan K, Brenner, Laura N, Gorshkova, Irina A, Berdyshev, Evgeny V, Tager, Andrew M, Shea, Barry S
Publicado 2014

Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis

por Ebrahimpour, Afshin, Ahir, Manisha, Wang, Min, Jegga, Anil G., Bonnen, Mark D., Eissa, N. Tony, Montesi, Sydney B., Raghu, Ganesh, Ghebre, Yohannes T.
Publicado 2022

Dynamic contrast-enhanced magnetic resonance imaging of the lung reveals important pathobiology in idiopathic pulmonary fibrosis

por Montesi, Sydney B., Zhou, Iris Y., Liang, Lloyd L., Digumarthy, Subba R., Mercaldo, Sarah, Mercaldo, Nathaniel, Seethamraju, Ravi T., Rosen, Bruce R., Caravan, Peter
Publicado 2021

Management of Lung Cancer in the Patient with Interstitial Lung Disease

por Frank, Angela J, Dagogo-Jack, Ibiayi, Dobre, Ioana A, Tait, Sarah, Schumacher, Lana, Fintelmann, Florian J, Fingerman, Leah M, Keane, Florence K, Montesi, Sydney B
Publicado 2022

Rituximab for interstitial pneumonia with autoimmune features at two medical centres

por D’Silva, Kristin M, Ventura, Iazsmin Bauer, Bolster, Marcy B, Castelino, Flavia V, Sharma, Amita, Little, Brent P, Adegunsoye, Ayodeji, Strek, Mary E, Choi, Hyon, Montesi, Sydney B
Publicado 2021

Ethnic and Sex Representation in Trials Shaping Best Practice for COVID-19

por Saleem, Danial, Gusman, Elen, Manson, Daniel K., Moore, Sarah K. L., Case, Meredith A., Klipper, Kaitlin M., Montesi, Sydney B., Serra, Alexis, Sundararajan, Radhika, Madahar, Purnema, Dzierba, Amy L., Abrams, Darryl, Beitler, Jeremy R.
Publicado 2021

Practical application and validation of the 2018 ATS/ERS/JRS/ALAT and Fleischner Society guidelines for the diagnosis of idiopathic pulmonary fibrosis

por Shih, Angela R., Nitiwarangkul, Chayanin, Little, Brent P., Roop, Benjamin W., Nandy, Sreyankar, Szabari, Margit V., Mercaldo, Nathaniel, Mercaldo, Sarah, Montesi, Sydney B., Muniappan, Ashok, Berigei, Sarita R., Lynch, David A., Sharma, Amita, Hariri, Lida P.
Publicado 2021

Noninvasive Quantification of Radiation-Induced Lung Injury using a Targeted Molecular Imaging Probe

por Abston, Eric, Zhou, Iris Y., Saenger, Jonathan A., Shuvaev, Sergey, Akam, Eman, Esfahani, Shadi A., Hariri, Lida P., Rotile, Nicholas J., Crowley, Elizabeth, Montesi, Sydney B., Humblet, Valerie, Arabasz, Grae, Catana, Ciprian, Fintelmann, Florian J., Caravan, Peter, Lanuti, Michael
Publicado 2023

ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis

por Lagares, David, Ghassemi-Kakroodi, Parisa, Tremblay, Caroline, Santos, Alba, Probst, Clemens K., Franklin, Alicia, Santos, Daniela M., Grasberger, Paula, Ahluwalia, Neil, Montesi, Sydney B., Shea, Barry S., Black, Katharine E., Knipe, Rachel, Blati, Meryem, Baron, Murray, Wu, Brian, Fahmi, Hassan, Gandhi, Rajiv, Pardo, Annie, Selman, Moisés, Wu, Jiangping, Pelletier, Jean-Pierre, Martel-Pelletier, Johanne, Tager, Andrew M., Kapoor, Mohit
Publicado 2017

Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model

por Axelsson Raja, Anna, Wakimoto, Hiroko, DeLaughter, Daniel M., Reichart, Daniel, Gorham, Joshua, Conner, David A., Lun, Mingyue, Probst, Clemens K., Sakai, Norihiko, Knipe, Rachel S., Montesi, Sydney B., Shea, Barry, Adam, Leonard P., Leinwand, Leslie A., Wan, William, Choi, Esther Sue, Lindberg, Eric L., Patone, Giannino, Noseda, Michela, Hübner, Norbert, Seidman, Christine E., Tager, Andrew M., Seidman, J. G., Ho, Carolyn Y.
Publicado 2022